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“This comes as no surprise, we’re emptying our supplies. We’re only thinking of 
the size of the pile of shit to buy. Over and over, we take what we want to take 
even if the bond with nature will break…”
Raised Fist, Killing It
Till mina älsklingar Leah och Robert

ABSTRACT
A diet rich in vegetables is recommended for health in general and is also associ-
ated with lower blood pressure. Research suggests that inorganic nitrate present 
in leafy green vegetables could be a contributing factor for the favourable effect. 
Nitrate from the diet is reduced to nitrite by oral bacteria and further metabolised 
to nitric oxide (NO) in blood and tissues. The nitrate-nitrite-NO pathway is an 
alternative way of NO formation in addition to endogenous NO production by the 
NO synthases. NO is a potent signalling molecule involved in regulation of blood 
flow and metabolic function. 
In subjects with pre-hypertension and hypertension (n = 231) the effect on blood 
pressure after supplementing with nitrate-rich vegetables or potassium nitrate for 
5 weeks was compared to low-nitrate vegetables. Also, we examined the handling 
of nitrate among women and men. Nitrate-rich leafy green vegetables or a nitrate 
pill did not lower 24 h ambulatory blood pressure in this patient group. However, 
the renal handling of nitrate seemed to differ between women and men at basal 
conditions. 
In another study we investigated if interruption of oral bacterial conversion of 
nitrate to nitrite could affect metabolic rate in healthy volunteers. In this cross 
over study, subjects used antiseptic mouthwash or placebo for 3 days followed 
by measurements of resting metabolic rate. There was no difference in resting 
metabolic rate after antiseptic mouthwash use. 
Lastly, the role of an acidic milieu in the gastric lumen for any acute blood pres-
sure effect of nitrite was studied. Healthy men were given a proton pump inhibitor 
or placebo pills prior to a bolus dose of nitrite. Interestingly, the blood pressure 
reduction caused by nitrite was blunted by the proton pump inhibitor indicating 
that a low gastric pH is required for bio-activation of orally administered nitrite. 
The studies in this thesis address cardiovascular and metabolic effects after sup-
plementing or blocking the nitrate-nitrite-NO pathway. They have generated novel 
insights about clinical application of dietary nitrate intake, sex differences in nitrate 
handling and bio-activation of nitrite. 
POPULÄRVETENSKAPLIG SAMMANFATTNING
Forskning visar att en kost rik på grönsaker kan sänka blodtrycket. Nitrat är ett 
ämne som finns naturligt i många grönsaker t ex rödbetor och gröna bladgrönsaker. 
För att nitrat ska bli aktivt behöver det omvandlas till nitrit och sedan kvävemo-
noxid (NO). Detta sker med hjälp av bakterier i munnen och enzymer i blod och 
vävnader. Ett lågt pH stimulerar NO bildningen. De senaste åren har flera studier 
visat att tillskott av nitrat sänker blodtrycket hos både friska och personer med högt 
blodtryck. I vår forskargrupp har vi undersökt om ett tillskott av ca 125 g gröna 
bladgrönsaker om dagen säker blodtrycket jämfört med grönsaker som innehåller 
väldigt lite nitrat. I studien ingick även en grupp som fick en tablett med samma 
mängd nitrat som bladgrönsakerna innehöll. På så sätt kunde vi studera om det var 
nitrat i bladgrönsakerna och inget annat som gav en eventuell effekt på blodtrycket. 
Resultatet från studien visade dock att gröna bladgrönsaker rika på nitrat eller en 
tablett med nitrat inte sänkte blodtrycket jämfört med grönsaker med lite nitrat. Vi 
såg däremot att det skiljer sig mellan kvinnor och män hur kroppen hanterar nitrat. 
Tillskott av nitrat har även visat kunna minska kroppens behov av syre och energi 
både i vila och vid träning. I en studie undersökte vi vilometabolismen (hur mycket 
energi som behövs vid vila) och om den förändras om vi hämmar bakterierna i 
munnen som hjälper till med omvandlingen av nitrat. Detta gjorde vi genom att 
deltagarna fick gurgla en antibakteriell munsköljning i tre dagar och sedan jämföra 
med munsköljning som inte påverkar bakterierna i munnen (placebo). Efter varje 
3-dagarsperiod av munsköljning mätte vi vilometabolismen. Den skilde sig inte 
åt mellan gångerna. Vi kunde däremot kontatera att deltagarna effektivt eliminerat 
munbakterierna med den antibakteriella munsköljningen.
Den bakteriella nitratreduktionen i munnen leder till relativt höga halter av nitrit 
i saliv. Vi undersökte betydelsen av magsäckens pH (surhetsgrad) för att vi ska 
kunna se en blodtryckseffekt av nitrit. Nitrit bildar NO i magen då pH är tillräckligt 
lågt. Personerna i studien fick en medicin som höjer pH i magsäcken alternativt 
en placebotablett dagarna före blodtrycksmätning. Deltagare fick sedan nitrit och 
därefter mätte vi blodtrycket under två timmar. Då deltagarna hade fått placebotab-
lett gick blodtrycket ner av nitrit, men när de tagit medicin som höjt pH i magen 
förändrades inte blodtrycket. Detta visar att ett lågt pH i magen är nödvändigt för 
att nitrit ska kunna sänka blodtrycket. 
Dessa studier har undersökt effekter av nitrat och nitrit på hjärta och kärl samt vilo-
metabolism. De har bidragit till ny information om effekt på blodtrycket efter ett 
ökat nitratintag genom bladgrönsaker, hur hanteringen av nitrat skiljer sig mellan 
kvinnor och män och betydelsen av lågt pH i magsäcken för aktivering av nitrit. 
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11 INTRODUCTION
The use of inorganic and organic nitrate has an interesting and long history. Already 
in the fifth century alchemist and physician Tao Hongjing described the medical 
use of saltpetre (KNO3). This inorganic salt was placed under the tongue to treat 
patients with chest pain (1). Over a thousand years later the organic nitrate nitro-
glycerin was discovered and its use in medicine begun. The Swedish researcher 
and entrepreneur Alfred Nobel could stabilize nitroglycerin and develop an explo-
sive well known as dynamite. The discovery made him extremely wealthy, and 
he used his fortune to create the Nobel Prizes. It was later realized that men with 
coronary disease who worked in the dynamite factories had fewer episodes with 
angina during work than over the weekend (2). Nitroglycerin and other organic 
nitrates are still used today to treat angina. However, this thesis will focus on the 
medical use of inorganic nitrate - the very old practice of Tao Hongjing.  
1.1 Nitric Oxide production 
Today we know that both inorganic and organic nitrates mediate their principal 
effects through the generation of nitric oxide (NO). NO is a tiny free radical gas 
and the discovery of endogenous NO production and signalling awarded Robert 
Furchgott, Louis Ignarro and Ferid Murad the Nobel Prize in Physiology or Medicine 
in 1998 (3-5). The molecule that was previously termed EDRF (endothelium-
derived relaxing factor) was now identified to be NO. 
In addition to its vasodilatory properties, NO is inhibiting leucocyte adhesion, 
platelet aggregation and vascular smooth muscle cell (VSMC) proliferation (6-8). 
NO is also produced in cardiac muscle where it is involved in regulating contrac-
tility (9). Consequently, NO has a central role in the cardiovascular system and 
reduced NO production and bioavailability are linked to several cardiovascular 
diseases (10).
Endogenously, NO is formed from NO-synthases (NOSs); which use the amino 
acid L-arginine and molecular oxygen as substrates (11). The NOSs exist in three 
isoforms: neuronal NOS (nNOS, NOS-1), inducible NOS (iNOS, NOS-2) and 
endothelial NOS (eNOS, NOS-3). Endothelial NOS is expressed in the vascular 
endothelium and regulates vascular tone and integrity (10). Activity and expres-
sion of eNOS decline with aging and this is also linked to hypertension (12). 
Constitutively expressed nNOS and eNOS produce moderate amount of NO under 
physiological conditions while induction of iNOS can lead to production of large 
amounts of NO as part of the immune response (13). 
2In vascular smooth muscle cells (VSMCs) NO stimulates soluble guanylyl cyclase 
(sGC) resulting in enhanced synthesis of the second messenger cyclic guanosine 
monophosphate (cGMP) which activates intracellular protein kinase G (PKG) ulti-
mately leading to relaxation of vascular smooth muscle (11). During hypoxia the 
oxygen-dependent L-arginine-NO pathway is less effective resulting in decreased 
NO production (10). Conversely, during oxidative stress NO bioavailability is also 
decreased partly due to scavenging of the NO radical by reactive oxygen species. 
NO is highly reactive with other radicals and transition metals, such as those found 
in haem proteins (14). Thus, in blood and tissues NO has a very short half-life and 
rapidly (from milliseconds to seconds) oxidises to nitrite (NO2-) and nitrate (NO3-) 
and with higher oxygen concentrations the rate of NO oxidation increases (15). 
1.2 The nitrate-nitrite-NO pathway
In 1994 two research groups independently showed that salivary nitrite could form 
NO in the stomach (16, 17). This was the first observation of an NO-synthase inde-
pendent pathway for NO generation. The year after Zweier and colleagues could 
demonstrate non-enzymatic NO generation from nitrite in the ischemic heart (18). 
These observations eventually lead to a new research field where supplementa-
tion of inorganic nitrate and nitrite can be used to enhance NO generation in vivo. 
Nitrate in blood and tissues derives from oxidation of endogenously produced 
NO and from the diet (19). Plasma levels can therefore vary greatly depending 
on these factors. Fasting nitrate and nitrite levels in humans are around 20-40 µM 
and 0.05-0.3 µM respectively (20). Endogenously produced nitrate is estimated to 
be around 60 mg/day (1 mmol/d) (21). Nitrate from food has almost 100 % bio-
availability (22) and plasma levels will peak after 15-30 minutes after ingestion 
with a half-life of 5-6h (19). 
Circulating plasma nitrate is actively taken up in the salivary glands (25 % of 
the systemic nitrate) and concentrated in saliva (23). In the oral cavity faculta-
tive anaerobic bacteria, mostly located to the posterior part of the tongue, reduce 
nitrate to nitrite (24). Identified bacteria species of importance for the oral nitrate 
reduction include Veillonella atypica, Veillonella dispar and Actinomyces odonto-
lyticus, but several other species are also efficient nitrate-reducers (25). Because 
of the active uptake and reduction of nitrate, salivary nitrate and nitrite are 100-
1000-fold higher than in plasma (26).
Once swallowed, nitrite is rapidly protonated in the acidic gastric lumen to form 
nitrous acid (HNO2), which then decomposes to NO and other nitrogen oxides in 
the stomach (27). This NO formation from nitrite is dependent on the low gastric 
pH, but also further enhanced by reducing agents such as dietary polyphenols 
3and ascorbic acid (19, 28, 29). A considerable amount of nitrite formed in saliva 
passes the stomach and is effectively taken up in the small intestine and enters the 
systemic circulation (30). In blood and tissues a number of proteins and enzymes 
have been found capable of further reducing nitrite to NO for example deoxyhae-
moglobin, deoxymyoglobin, xanthine oxidoreductase (XOR) and components of 
the mitochondrial respiratory chain (31).
Due to the enterosalivary circulation of nitrate described above and the continu-
ous swallowing of nitrite-containing saliva, plasma levels of nitrite will increase 
within 30 min after nitrate ingestion and stay elevated for several hours (32). The 
half-life of nitrite itself is only 20-30 min but the levels remain elevated because 
of continuous uptake of the more long-lived nitrate in the salivary glands (30).
Diminishing oral bacteria using an antiseptic mouthwash or antibiotics can nearly 
abolish the nitrate reducing capacity and also blunt the increase in plasma nitrite 
after a nitrate load (32). When using antiseptic mouthwash for seven days, oral 
nitrite production was reduced by 90 % and plasma nitrite levels with 25 % com-
pared to a control period (33) clearly showing the crucial role of oral bacteria in 
the nitrate-nitrite-NO pathway. 
Circulating nitrate is eventually excreted by the kidneys. A study using 15N-labeled 
nitrate showed that around 60 % of a nitrate dose is excreted in the urine within 
48 h (21). Supplementing with 10 mg/kg sodium nitrate increased concentrations 
of nitrate in urine from 0.8 mM to 8.1 mM in 3 hours (30). Also, intake of 120g of 
nitrate-rich lettuce for 3 days after a nitrate free diet resulted in four times higher 
nitrate levels in urine (34).
In summary, research performed during the past two decades verifies that nitrate 
and nitrite from dietary sources and from oxidation of endogenously produced 
NO can be recycled back to bioactive NO (20). This Nitrate-Nitrite-NO pathway 
represents an alternative way of NO generation in mammals in addition to the 
classical NOS-dependent pathway.
4Figure 1. Nitrate metabolism. Inorganic nitrate is metabolised to NO and other bioactive 
nitrogen oxides in humans. Ingested nitrate is efficiently taken up in the gastrointestinal 
tract and enters the blood stream. Circulating nitrate is partly excreted by the kidneys, but 
25 % is actively taken up by the salivary glands and secreted in saliva. In the oral cavity, 
salivary nitrate is reduced to nitrite by facultative anaerobic bacteria. In the acidic stom-
ach swallowed nitrite is non-enzymatically reduced to NO and other bioactive nitrogen 
oxides. Remaining nitrite reaches the systematic circulation and is reduced NO and other 
nitrogen oxides by several pathways in blood and tissue. Weitzberg & Lundberg, Annual 
Reviews of Nutrition 2013 (19).
51.3 Dietary sources of nitrate and nitrite 
Nitrogen (N2) is the most abundant gas in the atmosphere. It’s essential for all living 
organisms but to be biological active it needs to undergo fixation. Nitrogen-fixing 
bacteria convert nitrogen to ammonium (NH4+) and in a later step nitrifying bac-
teria oxidise ammonium to nitrite (NO2-) and then nitrate (NO3-). To complete the 
nitrogen cycle denitrifying bacteria eventually reduce nitrate back to nitrogen gas. 
Nitrate and nitrite are thereby a part of the nitrogen cycle and plays an important 
role in plant nutrition and function (35).
The main source of inorganic nitrate in the food is vegetables, which contribute 
with 60-80 % of the total intake (35). Table 1 show nitrate content in different 
vegetables. In certain meat-products (cured meat) nitrate and nitrite are added for 
colour, flavour and as preservatives, and this is responsible for 10-15 % of intake 
(36). Regarding nitrite 80-85 % stems from endogenous conversion of nitrate (37). 
Another major source of nitrate is the drinking water. In France it contributes with 
14 % of the total nitrate intake and 22 % in the UK (35).
In plants nitrate plays an important role for growth with the highest concentration 
found in leafy green vegetables and herbs (35). The use of fertilizers has a big 
impact on nitrate levels in leafy vegetables (38). Seasonal variation also determines 
nitrate content showing higher nitrate during the darker months of the year (35, 
39). UK grown lettuces showed a 24 % lower nitrate content in the summer than 
in the winter (40). Different handling of food and cooking methods can reduce 
nitrate content (35). Nitrate is highly water soluble and boiling vegetables for 15 
min showed a significant decrease in nitrate content with a parallel increase in 
the boiling water (41). 
A vegetarian diet has been shown to contain four times more nitrate compared to 
a non-vegetarian diet (42).  Consumption of leafy green vegetables, which are the 
most nitrate-rich vegetables, has been shown to reduce the risk for cardiovascular 
events in several epidemiological studies (43-45). Hung and colleagues showed 
that an increment of one serving of green leafy vegetables per day was inversely 
associated with cardiovascular disease (45). Another study showed that one serv-
ing of fruit or vegetables was associated with a 6 % lower risk of ischemic stroke 
and the authors identified leafy green vegetables as one of the greatest contributors 
to the protective effect (43). 
6Table 1. Nitrate content in vegetables measured by the European Food Safety Authority 
(EFSA)1 and by Lundberg laboratory2. ADI = Acceptable daily intake of nitrate. 
High nitrate 
vegetables
Mean nitrate 
content1 
mg/100g
Mean nitrate 
content2 
mg/100g
% of ADI 
for a 70kg 
person1
% of average 
intake1 in United 
Kingdom
Rocket/
Arugula
468 590 180 514
Spinach 106 158 40 116
Beetroot 138 443 53 152
Celery 110 514 43 121
Radish 97 143 38 107
Low-medium 
nitrate 
vegetables
Mean nitrate 
content1 
mg/100g
Mean nitrate 
content2 
mg/100g
% of ADI 
for a 70kg 
person1
% of average 
intake1 in United 
Kingdom
Peas 3 0.1 1 3
Tomato 4 0.6 2 4
Capsicum 11 0.3 4 12
Cucumber 19 23 7 21
Carrot 30 11 12 29
1.4 Nitrate intake and potential risks
The acceptable daily intake (ADI) of nitrate and nitrite according the European 
Food Safety Authority (EFSA) is 3.7 mg/kg/day (35). Nitrate intake varies between 
countries and regions. In Europe the mean intake is 50-180 mg/day (37). The 
Mediterranean countries have a higher intake than in northern Europe. In the United 
Kingdom nitrate and nitrite intake is approximately 91 mg/day and in France 141 
mg/day (35). Estimated intake in the United Stated is 40-100 mg/day (37). 
The proposed toxicity of nitrate is linked to its conversion to the more reactive nitrite 
anion. Nitrite can induce methaemoglobinaemia and result in hypoxia in tissues with 
severe consequences (37). Background levels of methaemoglobin are around 1-3 %. 
At 10 % methaemoglobin a reduced oxygen transport is evident, at levels above 20 
% cyanosis and hypoxia can occur and at 50 % methaemoglobin the outcome can 
be fatal (37). Lethal doses of nitrate in humans is estimated to be around 330 mg/
kg body weight and nitrite is approximately 10-fold more toxic (35). However, a 
patient case study reported that an intake of 75 g sodium nitrate (833 mg/kg body 
weight) resulted in instant gastrointestinal symptoms but no peripheral cyanosis 4 
h after intake (46). Infants younger than 3 months are more sensitive to methaemo-
globin formation due to 40-50 % lower activity of the enzyme (NADH-cytochrome 
b5 reductase) which converts methaemoglobin back to haemoglobin (47). 
For more than 50 years there has been extensive research in possible nitrosamine 
formation and cancer risk in relation to nitrate and nitrite intake. Animal studies 
on nitrate demonstrate low chronic toxicity and epidemiological studies do not 
7suggest that nitrate intake is associated with increased cancer risk (35). At the same 
time experimental human studies have shown increased levels of N-nitrosamines 
in the stomach after nitrate ingestion, using radioactive labelling confirming that 
the nitrogen originated from the given nitrate (48). Nitrite can form nitrosamines 
directly in the acidic stomach or in reactions catalysed by macrophages or bacteria 
(49, 50). The role of such nitrosamine formation is still not clear. A meta-analysis 
on gastric cancer in fact showed a reduced risk (RR 0.80) with dietary nitrate 
intake but an increased risk (RR 1.31) for nitrite (51). 
Dietary sources of nitrite include both animal-based products and vegetables. However, 
over 80 % of the total nitrite exposure is a result of endogenous conversion of nitrate 
(35). Summarizing experimental and epidemiological research on nitrate and nitrite 
the International Agency for Research on Cancer (IARC) concluded in 2010 that there 
is “inadequate evidence in humans for the carcinogenicity of nitrate in food” and 
that there is “limited evidence in humans for carcinogenicity of nitrite in food” (52). 
1.5 Nitrate and cardiovascular effects
In 2006 Larsen et al. demonstrated for the first time that intake of inorganic nitrate 
(0.1 mmol/kg for three consecutive days) lowered diastolic BP (-3.7 mmHg) in 
healthy volunteers (53). A few years later it was shown that 500 ml of nitrate-
rich beetroot juice (22.5 mmol) decreased systolic BP by -10.4 mmHg, an effect 
coinciding with the peak in plasma nitrite levels. Interestingly, BP levels were still 
reduced even 24 h after ingestion of beetroot juice (54). A more recent study on 
64 hypertensive patients measuring 24 h ambulatory BP after daily intake of 250 
ml beetroot juice (6.4 mmol nitrate) for 4 weeks showed a reduction in SBP of 
-7.7 mmHg and for DBP -5.2 mmHg (55). In this study a placebo beetroot juice 
was used in which the nitrate anions had been selectively removed using a resin. 
Interestingly, it has also been shown that 800 mg nitrate from beetroot juice, spin-
ach- and rocket-beverage lowered BP more than was seen with equal amount of 
sodium nitrate salt (56). In aggregate, numerous studies on healthy and hyperten-
sive subjects have now demonstrated a BP-lowering effect of nitrate intake (57). 
The threshold for the effect among healthy individuals has been suggested to lie 
between 4-12 mmol of nitrate (58). 
To investigate the role of endogenously generated nitrate on blood pressure Kapil 
and co-workers disrupted the nitrate-reducing capacity of the oral microflora with 
an antibacterial mouthwash for a week in healthy young subjects. This interven-
tion together with a low-nitrate diet markedly reduced salivary and plasma nitrite 
levels with a concomitant increase in SBP by 3.5 mmHg (33). An increase in 
SBP (2.3 mmHg) has also been seen in hypertensive subjects using antibacterial 
mouthwash for three days (59). These results indicate that endogenously gener-
ated nitrate (from NOS) participates in regulation of blood pressure and that the 
oral microflora is necessary for this physiological function. 
8The endothelium has a crucial role in regulation of vascular tone, platelet activity, 
leucocyte adhesion and thrombosis (60). A major feature of endothelial dysfunction 
is reduced NO synthesis from eNOS and/or reduced NO bioavailability (42). A 
widely used measurement of endothelial function is flow mediated dilation (FMD) 
where a change in brachial artery diameter is measured in response to hyperemia 
after a standardized period of ischemia. Intake of sodium nitrate 12.7 mg/kg 
(0.15 mmol/kg) has been shown to improve FMD (61). In another study as little 
as 1mg/kg improved FMD compared to placebo, indicating that the amounts of 
nitrate ingested by people on a daily basis may contribute to endothelial integrity 
(29). Also, plasma nitrite levels which can reflect NOS activity (62) are positively 
correlated with flow mediated dilation (FMD) (63). A meta-analysis concluded 
that nitrate and beetroot supplementation was associated with beneficial effects 
on endothelial function, but with a reduced effect in older subjects and those with 
greater cardio-metabolic risk (64).
1.6 Nitrate and oxygen consumption
Energy expenditure in humans is most often measured by indirect calorimetry. 
The measurement is based on consumed oxygen and release of carbon dioxide 
and the assumption that metabolic heat production is reflected by the amount of 
oxygen consumed.  
NO is involved in the control of mitochondrial respiration, and thereby energy 
regulation, by its reversible binding and inhibition of cytochrome c oxidase (COX) 
(65). COX is the terminal electron acceptor in the electron transport chain and the 
subunit COX IV-2 has been identified to strongly correlate to resting metabolic 
rate (RMR) (66). 
In 2007 it was discovered that oxygen cost at submaximal exercise was reduced 
after supplementation with sodium nitrate (0.1 mmol/kg) (67). A few years later 
the same group showed that freshly harvested human skeletal muscle mitochondria 
became more efficient (generated more ATP per consumed oxygen) after intake 
of the same amount of sodium nitrate (68). This improvement correlated strongly 
to the reduction in whole body oxygen cost during exercise, suggesting that the 
effects of nitrate on the mitochondria underly the improvement in aerobic effi-
ciency during exercise (68). Later, the same researchers showed a 4.2 % reduction 
in RMR in 13 healthy volunteers after 3 days of sodium nitrate 8.5 mg/kg/d (0.1 
mmol/kg/d) compared to a placebo salt (NaCl) (69). These studies indicate that 
nitrate supplementation alters oxygen demand and energy expenditure. 
92 AIMS
The overall aim of the thesis was to investigate the role of the nitrate-nitrite-NO 
pathway in regulation of blood pressure and metabolic rate. More specifically 
the aims were:
• To evaluate in a clinical trial the effects of leafy green vegetables on blood 
pressure in pre- and hypertensive subjects and elucidate if any such effect 
was due to their high nitrate content. 
• To study levels of nitrate and nitrite in plasma, saliva and urine after nitrate 
restriction and examine if there was any difference between women and men.
• To investigate if nitrate, originating from endogenous NO production, 
affects resting metabolic rate and blood pressure in healty subjects.
• To study the role of gastric acidity on the acute cardiovascular effects of 
nitrite. 
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3 MATERIAL AND METHODS
A summary of material and methods is presented below. For a more detailed 
description, see the material and method sections for each scientific paper. 
Study I: A randomized clinical trial of the effects of green leafy vegetables and 
inorganic nitrate on blood pressure
Study II: Nitrate and nitrite handling in hypertensive men and women
Study III: Effects of antiseptic mouthwash on resting metabolic rate: A randomized, 
double blind, cross over study
Study IV: Blood pressure-lowering effects of orally ingested nitrite is abolished 
by a proton pump inhibitor
3.1 Subjects 
In study I pre-hypertensive and hypertensive subjects (n = 231, SBP 130-159 mmHg, 
age 50-70 years) living in Stockholm County were enrolled. Exclusion criteria 
were cardiovascular event the last 6 months, changed dose of anti-hypertensive 
medication the past 2 months, use of nitroglycerine, proton pump inhibitors or 
insulin as an antidiabetic treatment. A detailed list of exclusion criteria is found 
in the manuscript. In Study II women (n = 122) and men (n = 109) from Study I 
were investigated with regard to handling of nitrate and nitrite. In Study III healthy 
women (n = 17, age 23 ± 4 years) were enrolled. Study IV was performed with 
two protocols both on healthy men (n = 15, age 30 ± 7 years and n = 8, age 36 ± 
16 years respectively). In Study III and IV subjects were not included if they were 
smokers or taking chronic medication.  
3.2 Nitrate and nitrite supplementation
In Study I eligible subjects first entered a 2-week run in period and were instructed 
to eat two portions (≈ 125 g/day) of low-nitrate vegetables (cherry tomatoes, pep-
pers, mini carrots and sweet corn) and exclude all other vegetables and legumes in 
their otherwise usual diet. After two weeks the subjects were randomized to one 
of three interventions on top of their usual diet: low nitrate vegetables + placebo 
pills (potassium chloride, twice daily), low-nitrate vegetables + nitrate pills (150 
mg of nitrate in the form of potassium nitrate, twice daily) or leafy green vegeta-
bles (amount adjusted to contain 150 mg nitrate, twice daily) + placebo pills. The 
subjects were instructed to take a pill with their given vegetables as a complement 
to their lunch and dinner. High nitrate vegetables included leafy green vegetables 
corresponding to 300 mg of nitrate daily (≈ 125 g/day). The weight of low nitrate 
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vegetables was matched after each measurement. The nitrate content of vegetables 
used in the study was measured two times per semester to calculate daily portions 
of high nitrate vegetables and a matched amount of low nitrate vegetables.
Estimated nutritional content for the different vegetable groups was also calculated 
(Table 2). The daily portions of high-nitrate vegetables and low-nitrate vegetables 
have only minor nutritional differences as calculated from data bases. The differ-
ence in energy between high nitrate vegetables and low nitrate vegetables is around 
40 kcal per day and a total of 1500 kcal for the intervention period of 5 weeks. 
Table 2. Estimated nutritional composition in the daily dose vegetables given in the 
DINO study. RI = Recommended Intake for adult women and men. Nordic Nutrition 
Recommendation 2012.
Macro nutrients RI/day High nitrate vegetables
Low nitrate 
vegetables Percent (%) of RI
kcal - 16 59 -
H2O (g) 1000-1500 110 99 11/10                                                   
Protein (g) - 1.6 1.6 -
Fat (g) - 0.2 0.3 -
Carbohydrates (g) - 1.3 11.1 -
Fibre (g) 25-35 1.4 2.1 6/8
Micro nutrients RI/day
Vitamin A RE (µg) 700-900 125 200 18/29
Vitamin D (µg) 10-20 0 0 0/0
Vitamin E (mg) 8-10 0.3 1.4 4/18
Thiamine (mg) 1.0-1.4 0.1 0 10/0
Riboflavin (mg) 1.2-1.6 0.1 0.1 8/8
Niacin (mg) 13-19 0.6 1 5/8
Vitamin B6 (mg) 1.2-1.5 0.1 0.2 8/17
Folate (µg) 300-400 84.4 41.7 28/14
Vitamin B12 (µg) 2 0 0 0/0
Vitamin C (mg) 75 10 66 13/89
Calcium (mg) 800 75 10 9/1
Phosphorus (mg) 600 37 43 6/7
Potassium (mg) 3100-3500 416 238 13/8
Sodium (mg) 2400 7 103 0.3/4
Magnesium (mg) 280-350 15 17 5/6
Iron (mg) 9-15 0.8 0.5 9/6
Zinc (mg) 7-9 0.58 0.41 8/6
Selenium (µg) 50-60 0.58 0.51 1/1
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A validation of the nitrate pill and vegetable intake in terms of bioavailability was 
performed prior to the start of Study I. Plasma levels of nitrate and nitrite after 
intake of nitrate-rich vegetables or KNO3 were evaluated in a pilot study before 
the study start. A cross over design was used in seven healthy volunteers. A base-
line blood sample (0 h) was taken before a standardized breakfast (0.5 h) together 
with either nitrate-rich vegetables (150 mg NO3-) or KNO3 (150 mg NO3-). Plasma 
nitrate and nitrite were measured by HPLC (ENO-20; EiCom) 4 h and 8 h after 
the baseline blood sample. Plasma nitrate and nitrite levels were not significantly 
different after vegetable intake compared to salt intake (Figure 2). 
Figure 2. Plasma nitrate and nitrite were measured at baseline, 4 h and 8 h after intake 
of 150 mg NO3-. Data was analysed with 2-way repeated measures ANOVA followed by 
Bonferroni post hoc analysis. There was no significant difference in plasma nitrate or nitrite 
after vegetables intake compared potassium nitrate intake. Data is presented as mean ± SD.
In Study III the subjects were instructed to only eat low-nitrate vegetables and avoid 
cured meat 3 days prior to the test day. Study IV was performed in two parts. In part 
one the subjects (were instructed not to eat any vegetables or cured meat the day 
before and during the test day. On the test day they got a bolus dose of 0.3 mg/kg 
sodium nitrite. In the second part of the protocol nitrite was infused intravenously 
at 3 different rates (1, 10 and 30 nmol/kg/min) for ten minutes at each dose.
3.3 Study procedures
The study procedure for Study I is presented in Table 3. The study included 10 visits 
in total for the subjects running over a period of minimum 7 weeks. In Study II 
data (blood-, saliva samples and 24 h urine collection) was extracted from screen-
ing visit 2 and from visit 7 in the placebo group. 
In Study III the subjects were randomised to rinse/gurgle their mouth for 1 min 
with placebo or chlorhexidine-containing mouthwash 3 times a day for 3 days prior 
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to measurements. The study had a cross over design and the 3-day intervention 
period was separated by 28 days. On the morning of the third day of intervention 
the subjects were instructed to attach a 24 h blood pressure monitor, collect urine 
and record their food intake. The following day the subjects returned after > 12 h 
fasting to measure body temperature, RMR, exhaled NO and office BP. Also, blood- 
and saliva samples were taken and a nitrate reducing ability test was performed. 
In the first part of Study IV the subjects were pre-treated with placebo or esome-
prazole (40 mg) 16, 8 and 1 hour before sodium nitrite intake. After nitrite intake, 
repeated BP measurements and blood sampling were performed during 2 hrs. In 
the second part, BP was measured immediately after each nitrite infusion period 
using a sphygmomanometer. A blood sample was collected after the final nitrite 
infusion period. 
Table 3. An overview of the protocol for each study visit in Study I.
Screening visit 1
Informed written consent
Major eligibility questions
Medical history
Blood pressure x 3, mean of the two last. If SBP is 135-169 mm Hg and DBP < 110 mm Hg 
proceed to next visit.
Screening visit 2
Blood pressure x 3, mean of the two last. If SBP is 130-159 mm Hg and/or
DBP < 110 mm Hg participants are included in the study.
General lifestyle questionnaire
Instructions for 3d dietary record
Height and weight
Body composition measurement
Saliva and tongue test
Run-in period (2 w)
Distribute materials and information for 24-h urine collection
Hand out low nitrate vegetables
Randomization visit – 1st test visit
Urine collection 24h
Blood pressure x 3, mean of the two last.
Blood sample
Saliva and tongue sample
Weight and body composition
Attach 24h BP monitor and 24h activity record
Randomise
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Intervention visit 1-3
Blood pressure x 3, mean of the two last.
Saliva sample
Weight and body composition
Hand out vegetables 
Intervention visit 4
Blood pressure x 3, mean of the two last.
Saliva sample
Weight and body composition
Hand out vegetables and pills
Instructions for 2nd 3d food record and urine collection
Intervention visit 5 – 2nd test visit
Urine collection 24h
Blood pressure x 3, mean of the two last.
Blood sample
Saliva and tongue sample
Weight and body composition
Attach 24h BP monitor and 24h activity record
General lifestyle questionnaire
3.4 Blood pressure measurements
Ambulatory blood pressure was performed using WatchBP® O3 (Microlife 
Corporation, Switzerland) validated by the European Society of Hypertension (ESH) 
for clinical, ambulatory and self-measurement. In Study I and II the monitor was 
programmed for one reading every 30 min for 24 h and in Study III every 30 min 
between 6 am -10pm and one reading every 1h between 10 pm-6 am. WatchBP® 
O3 Analyser Software was used to download readings and produce mean day- and 
night-time BP. In all studies clinic and office BP was measured using an Omron 
M10-IT (Omron Corporation, Japan). After a 5 min rest in a quiet room in a sit-
ting position, three measurements with 1.5 min intervals were taken in the upper 
arm (lower arm in an armrest, 90 degrees angle). The second and third readings 
were averaged to determine a mean clinic BP. All BP observers were blinded to 
the group assignment and participants were blinded to their BP data.
3.5 Measuring nitrate in vegetables
The first step involves finely chopping the vegetables using a mixer and then adding 
distilled water (3 times the weight). The vegetable solution is poured into Falcon 
tubes and stored in 56 C° water for 45 min (allowing the water soluble nitrate to 
15
equilibrate), followed by centrifugation (10 000 x g for 15min). The supernatant 
was pipetted to Eppendorf tubes and stored at -80 C°. Concentrations of nitrite 
and nitrate were determined by chemiluminescence after reductive cleavage and 
subsequent release of NO into the gas phase as described previously (30). 
3.6 Blood-, saliva and urine sampling
Blood samples were taken via standard venepuncture and using vacuum test tubes 
in which nitrite free EDTA solution (250 mmol/l; 8ul/ml blood) had been added. 
For measurements of plasma nitrate and nitrite the blood samples were centri-
fuged for 10 min, at 4 C° at, 2000 rpm and 0.5 ml aliquots plasma were pipetted 
into Eppendorf tubes (1.5 ml). Saliva samples (0.5ml) were collected in 1.5 ml 
Eppendorf tubes and frozen immediately. Urine was collected in sterile contain-
ers and the total time of the urine collection was documented by the subjects. The 
subjects were instructed to store the containers in the fridge when possible. Total 
urine volume was registered and aliquoted in Eppendorf tubes (0.5 ml). Plasma-, 
saliva- and urine samples were stored at -80 C° until nitrate and nitrite levels 
were measured using a HPLC system (ENO-20; EiCom) as previously described 
(32, 70). Nitrate and nitrite measurements were performed at a laboratory at the 
Department of Physiology and Pharmacology. Clinical laboratory tests (plasma 
lipids, glucose, electrolytes etc.) were measured in the central laboratory at 
Karolinska University Hospital.
3.7 Measuring resting metabolic rate
Resting metabolic rate (RMR) was measured using an indirect calorimetry system 
with a ventilated hood (Jaeger Oxycon Pro). The test started with a 15 min rest 
in a quiet dark room, after which RMR was recorded for 30 minutes. The low-
est oxygen uptake monitored for 10 consecutive minutes was used as a measure 
of RMR. The test was performed at a separate visit prior to the intervention to 
familiarize the subjects with the method.  Body temperature was measured with 
an ear thermometer (Braun ThermoScan) at each visit.
3.8 Statistics
In Study I a pre study power calculation was performed and a sample size of 60 
subjects per group was estimated to provide > 80 % power to detect a 3 mmHg 
difference in change in SBP between groups using unpaired comparison. Between-
group differences in change in BP were analysed with one-way ANOVA followed 
by Bonferroni post-hoc analysis. Within group comparison in BP was analysed 
with two-way repeated measures ANOVA also followed by Bonferroni post-hoc 
analysis. The weekly SBP and DBP were analysed with Linear Mixed Model. 
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Data are presented as means ± SD. D’Agostino & Pearson omnibus test was used 
to determine normal distribution of data. Tests were considered significant at a p 
value < 0.05. Statistical analysis was performed in Prism 5 and 6 software (Graph 
Pad) and STATA version 13 (StataCorp, Collage Station, TX, USA).
In Study II normally distributed data was analysed with paired or unpaired t-tests. 
Non-normally distributed data was analysed with Wilcoxon matched-paired signed 
rank test or Mann Whitney tests. Data are presented as means ± SD or median 
and 25-75 percentile.
In Study III paired t-test was used to compare mouthwash and placebo treatments. 
Data are presented as means ± SD or median and 25-75 percentile. 
In Study IV paired t-tests, 2-way ANOVA using Bonferroni post hoc analysis or 
1-way ANOVA followed by Dunnett multiple comparison tests were used. Data 
are presented as means ± SEM.
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4 RESULTS AND DISCUSSION
4.1  Study I
4.1.1 Adherence
In Study I the adherence to the protocol was evaluated with self-reported intake, 
blood and urine samples. The self-reported compliance to the vegetable and pill 
intake was > 97 % and > 98 % respectively. In accordance with these results, plasma 
nitrate increased significantly in the intervention groups while in the placebo group 
it remained unchanged compared to baseline levels (Table 4). However, only in 
the potassium nitrate group did the increase in plasma nitrite reach significance. 
The modest increase in nitrite levels in plasma could be explained by the time 
point of the sampling which was after an overnight fasting, i.e. around 12 h after 
the last nitrate intake. Saliva nitrate and nitrite increased in the groups receiving 
nitrate. Consistent with plasma and saliva, urinary nitrate excretion was similar 
(254 mg and 303 mg) in the groups receiving nitrate and close to the total amount 
nitrate given, confirming excellent compliance. 
Table 4. Nitrate (plasma, saliva and urine) and nitrite (plasma and saliva) before and 
after interventions. Within group comparison was analysed with repeated measures two-
way ANOVA followed by Bonferroni post-hoc analysis. 1Significantly different from 
pre value p < 0.05. 2Significantly different from pre value p < 0.0001. All values are pre-
sented as means ± SDs.
Groups Placebo Potassium Nitrate Leafy Green Vegetables
Pre Post Pre Post Pre Post
Nitrate
Plasma, 
µmol/L
31.2 ± 18.9 32.0 ± 20.2 30.6 ± 12.7 105 ± 52.42 30.4 ± 11.6 114 ± 57.92
Saliva, 
µmol/L
286 ± 449 315 ± 596 412 ± 432 1802 ± 16332 322 ± 353 1557 ± 14632
Urine, 
µmol/L
513 ± 296 526 ± 320 582 ± 291 2593 ± 11752 526 ± 297 2843 ± 11672
Excreted, 
mg/d
51.3 ± 23.1 53.0 ± 43.5 58.1 ± 30.1 254 ± 86.72 54.0 ± 29.7 303 ± 1272
Nitrite
Plasma 
µmol/L
0.34 ± 0.25 0.33 ± 0.28 0.36 ± 0.22 0.46 ± 0.381 0.39 ± 0.33 0.48 ± 0.45
Saliva, 
µmol/L
147 ± 192 158 ± 160 190 ± 185 604 ± 6332 186 ± 214 499 ± 6482
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4.1.2 Blood pressure
In this randomized, placebo-controlled clinical trial the primary outcome measure 
was difference in change in 24h ambulatory SBP (Figure 3). The numerical change 
in SBP was -0.6 ± 6.2 mmHg in the placebo group, -1.2 ± 6.6 mmHg in the potas-
sium nitrate group and -0.5 ± 6.6 mmHg in the leafy green vegetables group (all 
non-significant). Also, there was no significant difference in delta SBP between 
the groups. Clinic SBP taken before and in the last day of the intervention period 
showed a decrease in SBP in the potassium nitrate group (-4.3 ± 11.6 mmHg, p < 
0.001) but not in the leafy green vegetables group (-1.7 ± 11.2 mmHg, p = 0.181) 
or the placebo group (-1.3 ± 9.1 mmHg, p = 0.227) (Figure 3). 
In a recently published meta-analysis the effect of nitrate supplementation on 
BP has been evaluated with the conclusion that SBP is reduced by dietary nitrate 
intake (-4.1mmHg, p < 0.001) in clinic settings, but not with home- or ambulatory 
SBP measurements (57). Ambulatory BP measurements has been pointed out as 
a better predictor of hypertension mediated organ damage than office BP (71). 
Also, ambulatory BP measurements can identify white coat hypertension which 
is more common in older people and those with grade 1 hypertension (72). On the 
other hand a clinic BP performed in accordance with guidelines on the same time-
point of the day could be an easier tool to detect small (3-4 mmHg), but clinically 
relevant changes in SBP. In Study I night-time ambulatory SBP decreased from 
123 mmHg to 121 mmHg in the group receiving potassium nitrate (p = 0.041), 
suggesting that a more standardized measurement, during night-time when lying 
down, is needed to see minor changes in SBP. However, the largest previous study 
on the effect of nitrate in hypertensive subjects showed an impressive reduction in 
24 h ambulatory BP by -7.7/-5.2 mmHg and in clinic BP by -7.7/-2.4 mmHg after 
intake of ≈ 400 mg nitrate (55). In this study performed by Kapil and colleagues 
baseline ambulatory SBP was 148 and 149 mmHg in the placebo and intervention 
group, respectively and thereby nearly 20 mmHg higher than the mean baseline 
ambulatory SBP (131 mmHg) in Study I. The difference in starting BP could be 
an explanation of the contrasting study outcomes, although baseline BP have not 
been associated with effect size in the earlier mentioned meta-analysis on dietary 
nitrate and BP (57).
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Figure 3. Ambulatory BP (A, B) and Clinic BP (C, D) before and after intervention. There 
was no difference in difference in change in between group comparisons using 1-way 
ANOVA with Bonferroni correction. Within group comparisons were performed using 
2-way ANOVA followed by Bonferroni post hoc analysis. Clinic SBP (C) was significantly 
reduced in the potassium nitrate group after the intervention. 
The absence of a BP-lowering effect in Study I could be due to the amount of 
nitrate given daily. The dose of 300 mg/day was carefully chosen to be achiev-
able trough a normal diet and resulted in a mean of 4.0 mg nitrate/kg daily for the 
study subjects (4.4 mg/kg for women and 3.6 mg/kg for men). This means that 
the female subjects slightly exceeded EFSAs upper limit which is 3.7 mg nitrate/
kg/day (35). However, there was no correlation with dose/kg and effect on BP 
and the threshold is suggested to be 250 mg nitrate for a BP effect of nitrate (58). 
The effect of nitrate-rich leafy green vegetables on blood pressure has until today 
been investigated in two clinical trials other than Study I. Ashworth et al. (73) 
showed in a cross over study a -4 mmHg decrease in clinic SBP in normotensive 
healthy female volunteers (n = 19, mean age 20 years) after 1 week of high nitrate 
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vegetables (mainly leafy greens). Compared to our study there was a difference 
in age and baseline BP. Also, the participants were instructed to consume the veg-
etables 2.5-3 h before blood pressure measurement – that is when nitrite levels 
are peaking (32, 54). Indeed, the subjects had almost four-fold higher nitrite lev-
els than the subjects in Study I. This procedure could be viewed as a more acute 
experiment looking at BP compared to Study I. Moreover, 8 out of 19 subjects had 
no effect or an increased SBP after leafy green vegetable which makes it hard to 
draw firm conclusions. The second study performed by Bondonno et al. had more 
similarities with Study I (74). The amount of nitrate supplemented form leafy green 
vegetables was calculated to contain 300mg (the main source was frozen spinach) 
and the age group was 38-70 years old. In this controlled cross over study (n = 
38) they measured BP in three ways (ambulatory, clinic and home BP) but could 
not detect any changes with any of the methods when comparing 1 week of high-
nitrate vegetables with 1 week of nitrate restriction. The time-point of intake in 
relation to BP measurement seems to be crucial to detect an effect of leafy green 
vegetables. In Study I a small but significant decreases in SBP was seen in the 
potassium nitrate group (Figure 3, C) and not in the leafy green vegetable group 
and it cannot be excluded that some other compound present in leafy green veg-
etables attenuates the effect of nitrate. 
4.1.3 Sex differences
An interesting un-published observation in Study I was that females exhibited 
a significant drop in 24h ambulatory SBP in the potassium nitrate group (-2.5 
mmHg, p = 0.01), but no changes were seen in the leafy green vegetables group 
(-0.3 mmHg) or the placebo group (-1.3 mmHg, Figure 4). Also, clinic SBP in 
women was reduced by -5.5 mmHg (p = 0.004) in the potassium nitrate group. 
There was no significant reduction in clinic or ambulatory BP in men (Figure 4). 
In the study by Ashworth et al. mentioned earlier the young women had a reduction 
in SBP despite low baseline BP (73). However, in a study by Kapil and colleagues 
on sex differences related to the nitrate-nitrite-NO pathway, men had a greater 
numerical (non-significant) decrease in SBP (-6 mmHg) compared to women (-2 
mmHg) (75). Oestrogen has been shown to have a regulatory role on endogenous 
NO production (76). The women in Study I were post-menopausal and it is pos-
sible that hormonal changes influence the BP response in women of different ages 
but not in men. Any possible sex differences in the effect of nitrate on BP needs 
to be elucidated further.
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Figure 4. Ambulatory SBP in women (A) and men (B) and clinic SBP in women (C) and 
men (D) before and after intervention. Within group comparisons were performed using 
2-way ANOVA followed by Bonferroni post hoc analysis. Ambulatory SBP and clinic SBP 
in females (A, C) were significantly reduced in the potassium nitrate group. 
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4.2 Study II
4.2.1 Sex differences in nitrate excretion
Nitrate handling was investigated in women (n = 122) and men (n = 109) after 
two weeks of dietary nitrate restriction. The data in Study II were extracted from 
the participants in Study I. There was no difference in nitrate and nitrite levels in 
plasma or saliva between women and men (Table 5). However, plasma nitrite was 
close to significantly higher in women (0.38±0.24 in women and 0.34 ± 0.30 in 
men, p = 0.09). Nitrate concentrations in urine, excreted nitrate as well as nitrate 
clearance were all lower in women (p < 0.0001) as well as the fractional excretion 
of nitrate (p = 0.0013). This was apparent despite no difference in volumes of urine 
excreted during 24 h (1763 ± 642 ml/24h and 1791 ± 648 ml/24h in women and 
men respectively, p = 0.95) or estimated glomerular filtration rate (80.1 ± 11.5 
and 80.1 ± 8.4, p = 0.28). 
Circulating nitrate is commonly used as a surrogate marker of endogenous NO 
production but is not reliable when dietary nitrate intake is not controlled for. 
Study I had a relatively long and controlled period of low nitrate intake which 
gave us an opportunity to study endogenous NO production and renal handling 
of nitrate in depth. 
In the study by Kapil and colleagues mentioned earlier on sex differences in the 
nitrate-nitrite-NO pathway they reported higher nitrite levels in plasma, urine and 
saliva in women, but similar nitrate levels in all these matrices (75). They also 
performed analysis of oral nitrate reductase activity by holding a fixed volume of 
potassium nitrate in the mouth for 5 min which resulted in higher nitrite conver-
sion in women, but the authors found no sex differences in the composition of 
the oral microbiome. Also, after a given nitrate dose of 500 mg the fold increase 
in plasma nitrite was significantly higher in women compared to men. As men-
tioned above plasma nitrite was showing a trend towards higher levels in women 
in our study, which is partly in line with Kapil and colleagues, but salivary nitrite 
was not different (167 ± 196 µM in women and 182 ± 192 µM in men, p = 0.42). 
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Table 5. Nitrate (plasma, saliva and urine) and nitrite (plasma and saliva) after two weeks of 
low-nitrate diet. FEnitrate; renal fractional excretion of nitrate, Cnitrate; renal clearance of nitrate. 
Saliva ratio is salivary nitrite/salivary nitrate. Normally distributed data is analysed with 
unpaired t-test and non-normally distributed data with Mann-Whitney test. Values are pre-
sented as means ± SDs and ratio as median (Q1-Q3). 
Nitrate Women (n =122)
Men 
(n=109) Significance
Plasma (µM) 31.8 ± 13.3 29.6 ± 16.2 p = 0.10
Saliva (µM) 344 ± 380 391 ± 462 p = 0.75
Urine (µM) 469 ± 290 619 ± 281 p < 0.0001
Excretion (mg) 47.2 ± 28.3 62.5 ± 25.0 p < 0.0001
FEnitrate (%) 17.7 ± 7.70 20.8 ± 6.41 p < 0.01
Cnitrate (ml/min) 17.7 ± 8.19 26.1 ± 10.27 p < 0.0001
Nitrite
Plasma (µM) 0.38 ± 0.24 0.34 ± 0.30 p = 0.09
Saliva (µM) 167 ± 196 182 ± 192 p = 0.42
Saliva Ratio 0.43 (0.29-0.84) 0.46 (0.28-0.95) p = 0.89
In a study by Forte et al. on NO generation in healthy women and men (age 20-42 
years), L-[15N]2-guanidino arginine was administered intravenously and excreted 
urinary 15N nitrate was measured. Women excreted significantly more N15 nitrate 
and it was positively correlated to 17β-estradiol (77), indicating higher endogenous 
NO formation by NOS in women. Hormonal differences are one reason for dis-
crepancies in nitrate excretion and several studies have shown that estradiol treat-
ment increases eNOS activity (76, 78). In Study II females were post-menopausal 
which could explain the contrasting results and consequently we suggest a lower 
endogenous NO generation in women than in men in this age group. Moreover, 
a study in untreated hypertensive subjects using the same method as described 
above showed lower 15N nitrate excretion in hypertensive subjects compared to 
healthy controls (79). In both studies using the L-arginine isotope there was an 
inverse correlation between excreted nitrate and mean arterial blood pressure. We 
could not confirm these findings in our study.
In Study II we saw a clear difference in nitrate excretion, nitrate clearance and 
fractional excretion of nitrate between sexes indicating different renal handling of 
nitrate in women and men, at least in our cohort. Regarding the underlying mecha-
nisms, any differences in uptake of nitrate in the gastro-intestinal tract, storage 
ability in different tissues or the renal handling are still not clear.
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4.2.2 Time aspect of nitrate restriction 
We wanted to investigate if more prolonged dietary nitrate restriction would alter 
handling of nitrate and nitrite. The placebo group from Study I (n = 78) were on a 
low nitrate diet for 7 weeks in total, i.e. 5 additional weeks after the initial 2-week 
run in period. Table 6 show nitrate and nitrite levels in plasma, saliva and urine 
as well as the amount nitrate excreted after 7 weeks of a low nitrate diet among 
women (n = 42) and men (n = 36). The difference between women and men in 
urinary nitrate concentration, excreted nitrate, nitrate clearance and fractional 
extraction of nitrate was sustained for the additional 5 weeks of nitrate restric-
tion. In addition, plasma nitrite reached significantly higher levels in women in 
line with the study on sex differences by Kapil et al. (75). As of today Study I is 
the longest intervention on effects of a low nitrate diet, although several shorter 
placebo controlled supplementation studies have reported unchanged levels of 
plasma nitrate over periods of 1-4 weeks in the control group (55, 73, 74). 
Table 6. Nitrate and nitrite in plasma, saliva and urine after 7 weeks of low-nitrate diet. 
FEnitrate; renal fractional excretion of nitrate, Cnitrate; renal clearance of nitrate. Saliva ratio is 
salivary nitrite/salivary nitrate. Normally distributed data are analysed with unpaired t-tests 
and non-normally distributed data with Mann-Whitney tests. Values are presented as means ± 
SDs and ratio as median (Q1-Q3). 
Nitrate Women (n=42)
Men 
(n=36) Significance
Plasma (µM) 33.2 ± 12.2 32.0 ± 27.6 p = 0.06
Saliva (µM) 271 ± 270 364 ± 827 p = 0.79
Urine (µM) 445 ± 284 621 ± 336 p = 0.01
Excretion (mg) 40.9 ± 22.7 67.0 ± 56.4 p < 0.0001
FEnitrate (%) 15.8 ± 7.09 21.2 ± 6.53 p < 0.001
Cnitrate (ml/min) 14.9 ± 7.09 25.3 ± 10.1 p < 0.0001
Urine Volume 24h ml) 1712 ± 647 1906 ± 842 p = 0.25
Nitrite
Plasma (µM) 0.39 ± 0.33 0.25 ± 0.19 p = 0.04
Saliva (µM) 144 ± 94 173 ± 211 p = 0.76
Saliva ratio 0.53 (0.32-0.94) 0.53 (0.29-1.2) p = 0.70
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4.3 Study III
4.3.1 Adherence and efficacy of mouthwash
Adherence to protocol was tested with saliva samples and with an oral bacterial 
nitrate reducing capacity test (Figure 5). The subjects rinsed their mouth with 
sodium nitrate (10 ml, 10 mM) for 5 min. The solution was collected and nitrite 
and nitrite content was measured to examine how much of the nitrate had been 
converted to nitrite during the 5 min period. Salivary nitrate was significantly 
increased after mouthwash compared to placebo (p = 0.0029), while salivary nitrite 
was reduced (p = 0.0008), which confirmed excellent compliance and efficacy of 
the mouthwash intervention. Also, salivary nitrite levels accumulating during the 
oral bacterial nitrate reducing capacity test were significantly lower after mouth-
wash (p = 0.0003). No differences in plasma nitrate and nitrite or nitrate excretion 
during 24h was observed. 
Figure 5. Saliva nitrate (A), saliva nitrite (B), oral bacterial nitrate-reducing capacity (C) 
and 24 h urinary excretion of nitrate (D) after 3 days of placebo mouthwash compared with 
3 days of antibacterial mouthwash. Normally distributed data were analysed with paired 
t-tests and non-normally distributed data with Wilcoxon matched-pairs signed rank test. 
Values are presented as means ± SDs
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4.3.2 Resting metabolic rate 
The primary outcome RMR was not affected by mouthwash treatment being almost 
identical after mouthwash treatment compared to placebo (1089 vs 1088 kcal/day). 
Moreover, mouthwash did not alter respiratory exchange ratio. These results indi-
cate that mouthwash does not affect RMR or RER in healthy women (Figure 6). 
The time-point of measurement was adapted to be on the same days of the men-
strual cycle together with temperature measurements. Indeed, both inter-individual 
differences in RMR during the menstrual cycle (12 %) and intra-individual to 
range between 2-10 % (mean 4.6 %) has been reported (80). The intra-individual 
difference in RMR in women seems to be larger than in men (2-4%) (81) and to 
use a similar time point in the menstrual cycle is therefore essential for reliable 
comparisons of treatments in intervention studies. In a subsequent study on RMR 
in vegetarians and omnivores the authors reported a reduction in nitrate-reducing 
bacteria in both groups (≈ 17 %) after 1 week of antibacterial mouthwash but no 
difference in RMR in either group (82). In conclusion, blocking NO generation from 
endogenous nitrate does not seem to affect oxygen demand or energy expenditure 
as has been reported after nitrate supplementation (69). 
Figure 6. Resting metabolic rate (A) and respiratory exchange ratio (B) after 3 days of pla-
cebo mouthwash compared with 3 days of antibacterial mouthwash. Normally distributed 
data were analysed with paired t-tests and non-normally distributed data with Wilcoxon 
matched-pairs signed rank test. Values are presented as means ± SDs
4.3.3 Blood pressure
Ambulatory- or office BP did not change after antibacterial mouthwash use com-
pared to placebo mouthwash. These results are supported by the earlier mentioned 
study by Ashworth et al. on vegetarians and omnivores (82). However, in another 
study one week of antibacterial mouthwash increased SBP with 3mmHg (33). 
Moreover, Bondonno et al. reported a 2.3 mmHg SBP increase after 3 days use 
of antibacterial mouthwash in hypertensive men and women (59). In a study by 
27
Woessner et al. different strengths of mouthwash were used before a nitrate load 
and chlorhexidine/antibacterial but not antiseptic rinse eliminated the beneficial 
effect on SBP compared to a control (water) (83). In addition, SBP during treadmill 
walking was higher after chlorhexidine use followed by a nitrate dose compared 
to a control rinse (84).  
Baseline office BP in the women in Study III was normal (< 110mmHg SBP and 
< 80 mmHg DBP) compared to the subjects used in the study by Bondonno et al. 
It is possible that young females in the current study and the hypertensive subjects 
differ in their abilities to upregulate endogenous NO formation in response to 
inhibition of the nitrate-nitrite-NO pathway, although a cross talk between these 
NO pathways has so far only been demonstrated in rodents (85). 
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4.4 Study IV
4.4.1 Adherence and levels of nitrite and NO
In Study IV 15 healthy men were recruited to take placebo pills or esomeprazole 
prior to a bolus dose of sodium nitrite (0.3 mg/kg). BP measurements and blood 
sampling were performed at baseline and 2 h following intake. Plasma nitrite peaked 
to a similar degree in both groups after sodium nitrite intake, which indicates that 
uptake was not significantly altered by esomeprazole. Interestingly, nitrite levels 
decreased more rapidly in the placebo group. The effect of esomeprazole treatment 
on gastric acidity was indirectly evaluated in three subjects by measurement of 
NO levels in expelled air after sodium nitrite. Gastric NO formation from nitrite 
is strictly pH dependent so NO levels can to some extent be used as an indicator 
of acidity (16). Regurgitation of air was stimulated by drinking carbonated water. 
Indeed, in the control situation the mean expelled NO after nitrite was almost 600 
ppb and after intake of esomeprazole it was < 100 ppb indirectly confirming an 
increase in gastric pH. In the second part of the study sodium nitrite at three dif-
ferent doses (1, 10 and 30 nmol/kg/min for 10 min) was infused intravenously in 
8 healthy volunteers and blood pressure was measured at the end of each dose. 
Plasma nitrite reached 1.8 µM after the highest dose. 
Figure 7. Plasma nitrite changes after ingestion of sodium nitrite. Plasma nitrite levels 
were higher at 60 min after esomeprazole compared with placebo treatment. Two-way 
repeated-measures ANOVA with Bonferroni post hoc test was used for between group 
comparisons (# p < 0.05). Within group comparison with baseline (0 min) was performed 
with repeated measures ANOVA and Dunnett multiple comparison test (* p < 0.001). Data 
are shown as mean ± SEM. 
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4.4.2 Esomeprazole abolishes the effect of nitrate on blood 
pressure 
Blood pressure was not altered at baseline after intake of esomeprazole. When 
nitrite was ingested after placebo pre-treatment SBP was reduced by -6 mmHg at 
15 minutes. This nitrite-induced reduction was blunted after intake of esomepra-
zole. A significant difference in SBP response between the two interventions was 
sustained for an additional 30 minutes. There was no difference in DBP with or 
without intake of esomeprazole during the 2 h follow up. 
In part two of Study IV, nitrite was infused intravenously, but no significant effect 
on BP was observed despite nitrite in plasma reaching similar levels to the ones 
seen after oral nitrite administration. These findings suggest that bio-activation 
of nitrite occurs in the acidic environment of the stomach. The exact mechanisms 
for this activation, the identity of the final mediator for blood pressure reduction 
and the physiological role are not clear, but a protective role of maintaining a low 
gastric pH is supported by the association between increased risk of CVD and 
chronic use of proton pump inhibitors (86). 
Contrary to Study IV, other groups have reported a BP reduction after sodium 
nitrite infusion, albeit with higher doses than those used in the current study (87, 
88). As an example Cosby et al. reported increased forearm blood flow after infus-
ing nitrite (0.36 µmol/min and 36 µmol/min) in healthy subjects (89). Moreover, 
the robust reduction in SBP (-10 mmHg) following nitrate intake in the study by 
Webb et al. was seen when nitrite plasma levels were peaking (54). Still, in that 
study plasma nitrite was < 1uM and thereby around half of that seen in Study IV. 
It indicates that oral ingestion is needed for bio-activation of nitrite (and possi-
bly nitrate) with a subsequent BP effect. If this is true, earlier identified systemic 
pathways where nitrite is bio-activated by deoxygenated haemoglobin or xanthine 
oxidase, would be of minor importance, at least for the acute BP reduction seen 
after nitrite or nitrate intake.
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Figure 8. Blood pressure lowering effect of orally ingested sodium nitrite. Esomeprazole 
(40 mg) or placebo was taken at 3 separate time points (16, 8 and 1 h) before ingestion of 
sodium nitrite. Sodium nitrite ingestion was followed by a decrease in SBP after placebo 
pre-treatment but not after esomeprazole treatment. Two-way repeated-measures ANOVA 
with Bonferroni post hoc test was used for between group comparisons (# p < 0.05). Within 
group comparison was performed with repeated measures ANOVA and Dunnett multiple 
comparison test (* p < 0.05). Data are shown as mean ± SEM.
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5 CONCLUSIONS
• Dietary supplementation with leafy green vegetables or pills containing 
the same amount of inorganic nitrate does not decrease ambulatory SBP 
in subjects with elevated blood pressure. 
• Basal urinary nitrate concentration, fractional excretion of nitrate and 24 
h nitrate excretion differs significantly between women and men.
• Antiseptic mouthwash during 3 days does not alter resting metabolic rate 
or blood pressure in healthy young females.
• The acute blood pressure lowering effect of oral nitrite is abolished by a 
proton pump inhibitor. 
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6 FUTURE PERSPECTIVES
6.1 Dietary recommendation for blood pressure 
regulation
High systolic blood pressure has been identified as the risk factor associated with 
the greatest burden of disease worldwide (90). This is not surprising given the fact 
that over 1 billion people worldwide suffer from hypertension and that it is closely 
linked to increased risk of heart, brain and kidney disease (91). Moreover, from a 
population perspective a modest reduction in SBP by -2 mmHg can reduce stroke 
mortality with 10 % and mortality from ischemic heart disease with 5 % (92). 
Elevated BP is a result of many factors including an unhealthy diet, physical 
inactivity, stress, genetic factors etc. Among the environmental factors diet has 
been pointed out to have the predominant role in BP homeostasis (93). Dietary 
regimes like the DASH diet has been showed to lower SBP by -5.5 mmHg and 
DBP by -3 mmHg (94). Also, a vegetarian diet is associated with lower BP (95). 
Alone, sodium reduction to 2.3g/day can decrease BP with -3.8 mmHg SBP (96). 
Furthermore, weight control is closely related to hypertension. A meta-analysis 
concluded that 5.1 kg weight loss reduced SBP with -4.4 mmHg and DBP with 
-3.6 mmHg in average (97). Evaluation of cost-efficient lifestyle programs with 
focus on education in dietary habits and weight control is needed for this large 
patient group. 
6.2 Nitrate intake and blood pressure 
Inorganic nitrate and the effect on BP have been studied intensely for over a dec-
ade. Supplementing with nitrate from natural dietary sources (vegetables) has no 
known side effects and has the potential of being a safe and cost-efficient alternative 
to conventional BP pharmaceuticals. In Study I we could conclude that a dose of 
nitrate achievable through dietary intake could not lower SBP in pre-hypertensive 
and hypertensive subjects. Future studies need to investigate in which patient group 
(and responder characteristics) nitrate supplementation could have a clinically rel-
evant effect. It is likely that the BP effect seen after nitrate intake only is evident 
under very controlled conditions and blunted in studies using out of clinic BP 
measurements. This has been indicated in a recently published meta-analysis (57). 
The pathway for the acute BP lowering effect after nitrate intake has still not been 
fully elucidated. The role of the acidic milieu in the gastric lumen for bio-activation 
of nitrite has been discussed in this thesis, but mechanisms for potential signalling 
pathways via different complexes formed with nitrite or NO, the role of nitrite-
reducing pathways, potential altered nerve signalling and possible involvement 
of vasoactive hormones need to be further investigated. 
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For future therapeutic use and effective communication with patients, the dose of 
nitrate needs to be pinpointed. That dose will most likely exceed the current upper 
limit by EFSA (3.7 mg/kg body weight) (35), for a large part of the population. 
Recommendations regarding dietary nitrate need to be discussed and re-evaluated 
with regard to cardiovascular benefits versus potential cancer risk. Several epide-
miological studies on fruit and vegetable intake have identified nitrate-rich leafy 
green vegetables as the food group associated with the greatest cardiovascular 
protection (43-45). Moreover, ongoing experimental studies show that nitrate and 
nitrite have a protective effect in ischemia-reperfusion injury models. Interestingly, 
a long term randomized intervention study on Mediterranean diet and cardiovascu-
lar complications reported that the diet did not alter the usual relationship between 
traditional risk factors (blood pressure, blood lipids etc.), but reduced incidence of 
CV events independently (98). Study I showed a neutral effect on blood pressure 
after supplementing with leafy green vegetables for 5 weeks. Future trials should 
elucidate if dietary nitrate intake could provide a long-term protection against car-
diovascular morbidity and mortality through other mechanisms than those related 
to blood pressure reduction. 
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